nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—Faecaloma—Liotrix—hypothyroidism	0.0176	0.0328	CcSEcCtD
Ziprasidone—Faecalith—Liotrix—hypothyroidism	0.0176	0.0328	CcSEcCtD
Ziprasidone—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0173	0.0323	CcSEcCtD
Ziprasidone—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0173	0.0323	CcSEcCtD
Ziprasidone—Muscle twitching—Liothyronine—hypothyroidism	0.0142	0.0264	CcSEcCtD
Ziprasidone—Hyperthyroidism—Liotrix—hypothyroidism	0.0127	0.0237	CcSEcCtD
Ziprasidone—Phlebitis—Liothyronine—hypothyroidism	0.0117	0.0219	CcSEcCtD
Ziprasidone—HTR2A—cerebellar cortex—hypothyroidism	0.0106	0.0412	CbGeAlD
Ziprasidone—Swelling face—Liotrix—hypothyroidism	0.0106	0.0197	CcSEcCtD
Ziprasidone—Throat tightness—Liotrix—hypothyroidism	0.0103	0.0191	CcSEcCtD
Ziprasidone—DRD1—nerve—hypothyroidism	0.01	0.0388	CbGeAlD
Ziprasidone—HTR3A—nerve—hypothyroidism	0.00967	0.0375	CbGeAlD
Ziprasidone—Angina pectoris—Liothyronine—hypothyroidism	0.00852	0.0159	CcSEcCtD
Ziprasidone—DRD4—heart—hypothyroidism	0.00738	0.0286	CbGeAlD
Ziprasidone—CYP1A2—urine—hypothyroidism	0.00723	0.028	CbGeAlD
Ziprasidone—Feeling hot—Liotrix—hypothyroidism	0.00642	0.0119	CcSEcCtD
Ziprasidone—HTR7—nerve—hypothyroidism	0.00626	0.0242	CbGeAlD
Ziprasidone—Arrhythmia—Liothyronine—hypothyroidism	0.00625	0.0116	CcSEcCtD
Ziprasidone—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00597	0.0111	CcSEcCtD
Ziprasidone—Hyperkinesia—Levothyroxine—hypothyroidism	0.00597	0.0111	CcSEcCtD
Ziprasidone—DRD2—nerve—hypothyroidism	0.00591	0.0229	CbGeAlD
Ziprasidone—HTR2A—urine—hypothyroidism	0.00565	0.0219	CbGeAlD
Ziprasidone—Hypocalcaemia—Liotrix—hypothyroidism	0.0055	0.0102	CcSEcCtD
Ziprasidone—Oliguria—Liotrix—hypothyroidism	0.00547	0.0102	CcSEcCtD
Ziprasidone—Creatinine increased—Liotrix—hypothyroidism	0.00529	0.00985	CcSEcCtD
Ziprasidone—Increased appetite—Levothyroxine—hypothyroidism	0.00529	0.00985	CcSEcCtD
Ziprasidone—Increased appetite—Dextrothyroxine—hypothyroidism	0.00529	0.00985	CcSEcCtD
Ziprasidone—Hypertension—Liothyronine—hypothyroidism	0.00526	0.0098	CcSEcCtD
Ziprasidone—CYP3A4—urine—hypothyroidism	0.00523	0.0203	CbGeAlD
Ziprasidone—CYP2D6—urine—hypothyroidism	0.00515	0.02	CbGeAlD
Ziprasidone—Muscle twitching—Liotrix—hypothyroidism	0.00513	0.00955	CcSEcCtD
Ziprasidone—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00509	0.00948	CcSEcCtD
Ziprasidone—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00509	0.00948	CcSEcCtD
Ziprasidone—Tachycardia—Liothyronine—hypothyroidism	0.00485	0.00904	CcSEcCtD
Ziprasidone—Blood urea increased—Liotrix—hypothyroidism	0.00475	0.00885	CcSEcCtD
Ziprasidone—Hypotension—Liothyronine—hypothyroidism	0.00465	0.00866	CcSEcCtD
Ziprasidone—Dehydration—Dextrothyroxine—hypothyroidism	0.00462	0.00861	CcSEcCtD
Ziprasidone—Dehydration—Levothyroxine—hypothyroidism	0.00462	0.00861	CcSEcCtD
Ziprasidone—DRD4—testis—hypothyroidism	0.00456	0.0177	CbGeAlD
Ziprasidone—Lightheadedness—Liotrix—hypothyroidism	0.00451	0.00839	CcSEcCtD
Ziprasidone—HTR1E—female gonad—hypothyroidism	0.00443	0.0172	CbGeAlD
Ziprasidone—Hyperkinesia—Liotrix—hypothyroidism	0.00439	0.00818	CcSEcCtD
Ziprasidone—Sepsis—Liotrix—hypothyroidism	0.00437	0.00814	CcSEcCtD
Ziprasidone—Dysphagia—Levothyroxine—hypothyroidism	0.0043	0.008	CcSEcCtD
Ziprasidone—Dysphagia—Dextrothyroxine—hypothyroidism	0.0043	0.008	CcSEcCtD
Ziprasidone—Phlebitis—Liotrix—hypothyroidism	0.00424	0.0079	CcSEcCtD
Ziprasidone—Sweating increased—Levothyroxine—hypothyroidism	0.00418	0.00779	CcSEcCtD
Ziprasidone—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00418	0.00779	CcSEcCtD
Ziprasidone—Sweating increased—Dextrothyroxine—hypothyroidism	0.00418	0.00779	CcSEcCtD
Ziprasidone—Angina pectoris—Levothyroxine—hypothyroidism	0.00418	0.00779	CcSEcCtD
Ziprasidone—Renal failure acute—Liotrix—hypothyroidism	0.00396	0.00737	CcSEcCtD
Ziprasidone—Body temperature increased—Liothyronine—hypothyroidism	0.00393	0.00732	CcSEcCtD
Ziprasidone—HTR2A—nerve—hypothyroidism	0.0039	0.0151	CbGeAlD
Ziprasidone—H1F0—adrenal cortex—hypothyroidism	0.00389	0.0151	CbGeAlD
Ziprasidone—Increased appetite—Liotrix—hypothyroidism	0.00389	0.00725	CcSEcCtD
Ziprasidone—Weight decreased—Levothyroxine—hypothyroidism	0.00389	0.00724	CcSEcCtD
Ziprasidone—Weight decreased—Dextrothyroxine—hypothyroidism	0.00389	0.00724	CcSEcCtD
Ziprasidone—Renal impairment—Liotrix—hypothyroidism	0.00384	0.00715	CcSEcCtD
Ziprasidone—H1F0—heart—hypothyroidism	0.00376	0.0146	CbGeAlD
Ziprasidone—Hypoglycaemia—Liotrix—hypothyroidism	0.00375	0.00698	CcSEcCtD
Ziprasidone—Cerebrovascular accident—Liotrix—hypothyroidism	0.00373	0.00695	CcSEcCtD
Ziprasidone—Sweating—Levothyroxine—hypothyroidism	0.00367	0.00684	CcSEcCtD
Ziprasidone—Sweating—Dextrothyroxine—hypothyroidism	0.00367	0.00684	CcSEcCtD
Ziprasidone—H1F0—cardiovascular system—hypothyroidism	0.00355	0.0138	CbGeAlD
Ziprasidone—CHRM4—testis—hypothyroidism	0.00345	0.0134	CbGeAlD
Ziprasidone—Blood creatinine increased—Liotrix—hypothyroidism	0.00343	0.00638	CcSEcCtD
Ziprasidone—Dehydration—Liotrix—hypothyroidism	0.0034	0.00633	CcSEcCtD
Ziprasidone—DRD5—female gonad—hypothyroidism	0.00339	0.0131	CbGeAlD
Ziprasidone—Hypokalaemia—Liotrix—hypothyroidism	0.00333	0.0062	CcSEcCtD
Ziprasidone—H1F0—gonad—hypothyroidism	0.00322	0.0125	CbGeAlD
Ziprasidone—Dysphagia—Liotrix—hypothyroidism	0.00316	0.00588	CcSEcCtD
Ziprasidone—H1F0—pituitary gland—hypothyroidism	0.00314	0.0122	CbGeAlD
Ziprasidone—Angina pectoris—Liotrix—hypothyroidism	0.00308	0.00573	CcSEcCtD
Ziprasidone—Sweating increased—Liotrix—hypothyroidism	0.00308	0.00573	CcSEcCtD
Ziprasidone—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00307	0.00572	CcSEcCtD
Ziprasidone—Arrhythmia—Levothyroxine—hypothyroidism	0.00307	0.00572	CcSEcCtD
Ziprasidone—Alopecia—Levothyroxine—hypothyroidism	0.00304	0.00566	CcSEcCtD
Ziprasidone—Alopecia—Dextrothyroxine—hypothyroidism	0.00304	0.00566	CcSEcCtD
Ziprasidone—CHRM2—heart—hypothyroidism	0.003	0.0116	CbGeAlD
Ziprasidone—CYP3A7—liver—hypothyroidism	0.00296	0.0115	CbGeAlD
Ziprasidone—Weight decreased—Liotrix—hypothyroidism	0.00286	0.00532	CcSEcCtD
Ziprasidone—HTR1B—cardiovascular system—hypothyroidism	0.00284	0.011	CbGeAlD
Ziprasidone—CHRM2—cardiovascular system—hypothyroidism	0.00283	0.011	CbGeAlD
Ziprasidone—H1F0—adrenal gland—hypothyroidism	0.00281	0.0109	CbGeAlD
Ziprasidone—H1F0—blood—hypothyroidism	0.00281	0.0109	CbGeAlD
Ziprasidone—Tremor—Levothyroxine—hypothyroidism	0.0028	0.00522	CcSEcCtD
Ziprasidone—Tremor—Dextrothyroxine—hypothyroidism	0.0028	0.00522	CcSEcCtD
Ziprasidone—Renal failure—Liotrix—hypothyroidism	0.00277	0.00516	CcSEcCtD
Ziprasidone—HTR1D—cardiovascular system—hypothyroidism	0.00275	0.0107	CbGeAlD
Ziprasidone—Agitation—Dextrothyroxine—hypothyroidism	0.00275	0.00512	CcSEcCtD
Ziprasidone—Agitation—Levothyroxine—hypothyroidism	0.00275	0.00512	CcSEcCtD
Ziprasidone—Angioedema—Dextrothyroxine—hypothyroidism	0.00274	0.00509	CcSEcCtD
Ziprasidone—Angioedema—Levothyroxine—hypothyroidism	0.00274	0.00509	CcSEcCtD
Ziprasidone—H1F0—thyroid gland—hypothyroidism	0.00271	0.0105	CbGeAlD
Ziprasidone—Sweating—Liotrix—hypothyroidism	0.0027	0.00503	CcSEcCtD
Ziprasidone—HTR3A—blood—hypothyroidism	0.00268	0.0104	CbGeAlD
Ziprasidone—Palpitations—Dextrothyroxine—hypothyroidism	0.00265	0.00493	CcSEcCtD
Ziprasidone—Palpitations—Levothyroxine—hypothyroidism	0.00265	0.00493	CcSEcCtD
Ziprasidone—H1F0—female gonad—hypothyroidism	0.00262	0.0102	CbGeAlD
Ziprasidone—CHRM1—cardiovascular system—hypothyroidism	0.00257	0.00997	CbGeAlD
Ziprasidone—Arthralgia—Levothyroxine—hypothyroidism	0.00255	0.00475	CcSEcCtD
Ziprasidone—Arthralgia—Dextrothyroxine—hypothyroidism	0.00255	0.00475	CcSEcCtD
Ziprasidone—Anxiety—Levothyroxine—hypothyroidism	0.00254	0.00473	CcSEcCtD
Ziprasidone—Anxiety—Dextrothyroxine—hypothyroidism	0.00254	0.00473	CcSEcCtD
Ziprasidone—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00252	0.00976	CbGeAlD
Ziprasidone—Hypoaesthesia—Liotrix—hypothyroidism	0.00252	0.00469	CcSEcCtD
Ziprasidone—Confusional state—Dextrothyroxine—hypothyroidism	0.00246	0.00459	CcSEcCtD
Ziprasidone—Confusional state—Levothyroxine—hypothyroidism	0.00246	0.00459	CcSEcCtD
Ziprasidone—Shock—Levothyroxine—hypothyroidism	0.0024	0.00448	CcSEcCtD
Ziprasidone—Shock—Dextrothyroxine—hypothyroidism	0.0024	0.00448	CcSEcCtD
Ziprasidone—Tachycardia—Levothyroxine—hypothyroidism	0.00238	0.00444	CcSEcCtD
Ziprasidone—Tachycardia—Dextrothyroxine—hypothyroidism	0.00238	0.00444	CcSEcCtD
Ziprasidone—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00236	0.0044	CcSEcCtD
Ziprasidone—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00236	0.0044	CcSEcCtD
Ziprasidone—H1F0—testis—hypothyroidism	0.00232	0.00901	CbGeAlD
Ziprasidone—HTR7—heart—hypothyroidism	0.00232	0.009	CbGeAlD
Ziprasidone—HTR1A—cardiovascular system—hypothyroidism	0.00229	0.00889	CbGeAlD
Ziprasidone—Arrhythmia—Liotrix—hypothyroidism	0.00226	0.00421	CcSEcCtD
Ziprasidone—ADRA1A—heart—hypothyroidism	0.00224	0.00868	CbGeAlD
Ziprasidone—Alopecia—Liotrix—hypothyroidism	0.00223	0.00416	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00223	0.00414	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00223	0.00414	CcSEcCtD
Ziprasidone—Insomnia—Levothyroxine—hypothyroidism	0.00221	0.00411	CcSEcCtD
Ziprasidone—Insomnia—Dextrothyroxine—hypothyroidism	0.00221	0.00411	CcSEcCtD
Ziprasidone—ADRA2C—adrenal cortex—hypothyroidism	0.00221	0.00856	CbGeAlD
Ziprasidone—H1F0—liver—hypothyroidism	0.0022	0.00851	CbGeAlD
Ziprasidone—HTR7—cardiovascular system—hypothyroidism	0.00219	0.0085	CbGeAlD
Ziprasidone—Dyspnoea—Levothyroxine—hypothyroidism	0.00218	0.00406	CcSEcCtD
Ziprasidone—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00218	0.00406	CcSEcCtD
Ziprasidone—Flatulence—Liotrix—hypothyroidism	0.00217	0.00404	CcSEcCtD
Ziprasidone—KCNH2—heart—hypothyroidism	0.00216	0.00839	CbGeAlD
Ziprasidone—H1F0—cerebellum—hypothyroidism	0.00215	0.00832	CbGeAlD
Ziprasidone—ADRA2C—heart—hypothyroidism	0.00213	0.00827	CbGeAlD
Ziprasidone—ADRA1A—cardiovascular system—hypothyroidism	0.00211	0.00819	CbGeAlD
Ziprasidone—Fatigue—Levothyroxine—hypothyroidism	0.00211	0.00392	CcSEcCtD
Ziprasidone—Fatigue—Dextrothyroxine—hypothyroidism	0.00211	0.00392	CcSEcCtD
Ziprasidone—Vision blurred—Liotrix—hypothyroidism	0.00207	0.00386	CcSEcCtD
Ziprasidone—Tremor—Liotrix—hypothyroidism	0.00206	0.00384	CcSEcCtD
Ziprasidone—SLC6A4—blood—hypothyroidism	0.00204	0.00792	CbGeAlD
Ziprasidone—KCNH2—cardiovascular system—hypothyroidism	0.00204	0.00791	CbGeAlD
Ziprasidone—Agitation—Liotrix—hypothyroidism	0.00202	0.00377	CcSEcCtD
Ziprasidone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00201	0.00375	CcSEcCtD
Ziprasidone—Feeling abnormal—Levothyroxine—hypothyroidism	0.00201	0.00375	CcSEcCtD
Ziprasidone—Angioedema—Liotrix—hypothyroidism	0.00201	0.00375	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.002	0.00372	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.002	0.00372	CcSEcCtD
Ziprasidone—HTR7—gonad—hypothyroidism	0.00199	0.00771	CbGeAlD
Ziprasidone—Syncope—Liotrix—hypothyroidism	0.00197	0.00368	CcSEcCtD
Ziprasidone—Palpitations—Liotrix—hypothyroidism	0.00195	0.00362	CcSEcCtD
Ziprasidone—Urticaria—Levothyroxine—hypothyroidism	0.00194	0.00361	CcSEcCtD
Ziprasidone—Urticaria—Dextrothyroxine—hypothyroidism	0.00194	0.00361	CcSEcCtD
Ziprasidone—Loss of consciousness—Liotrix—hypothyroidism	0.00194	0.0036	CcSEcCtD
Ziprasidone—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00193	0.0036	CcSEcCtD
Ziprasidone—Abdominal pain—Levothyroxine—hypothyroidism	0.00193	0.0036	CcSEcCtD
Ziprasidone—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00193	0.0036	CcSEcCtD
Ziprasidone—Body temperature increased—Levothyroxine—hypothyroidism	0.00193	0.0036	CcSEcCtD
Ziprasidone—Hypertension—Liotrix—hypothyroidism	0.0019	0.00354	CcSEcCtD
Ziprasidone—Arthralgia—Liotrix—hypothyroidism	0.00187	0.00349	CcSEcCtD
Ziprasidone—Chest pain—Liotrix—hypothyroidism	0.00187	0.00349	CcSEcCtD
Ziprasidone—Anxiety—Liotrix—hypothyroidism	0.00187	0.00348	CcSEcCtD
Ziprasidone—DRD2—pituitary gland—hypothyroidism	0.00183	0.00711	CbGeAlD
Ziprasidone—HTR1A—adrenal gland—hypothyroidism	0.00181	0.00703	CbGeAlD
Ziprasidone—Confusional state—Liotrix—hypothyroidism	0.00181	0.00337	CcSEcCtD
Ziprasidone—KCNH2—pituitary gland—hypothyroidism	0.00181	0.00701	CbGeAlD
Ziprasidone—Infection—Liotrix—hypothyroidism	0.00179	0.00332	CcSEcCtD
Ziprasidone—ADRA2C—pituitary gland—hypothyroidism	0.00178	0.00691	CbGeAlD
Ziprasidone—Shock—Liotrix—hypothyroidism	0.00177	0.00329	CcSEcCtD
Ziprasidone—CHRM3—thyroid gland—hypothyroidism	0.00176	0.00681	CbGeAlD
Ziprasidone—Tachycardia—Liotrix—hypothyroidism	0.00175	0.00327	CcSEcCtD
Ziprasidone—Asthenia—Dextrothyroxine—hypothyroidism	0.00175	0.00326	CcSEcCtD
Ziprasidone—Asthenia—Levothyroxine—hypothyroidism	0.00175	0.00326	CcSEcCtD
Ziprasidone—Hyperhidrosis—Liotrix—hypothyroidism	0.00174	0.00323	CcSEcCtD
Ziprasidone—HTR7—adrenal gland—hypothyroidism	0.00173	0.00672	CbGeAlD
Ziprasidone—HTR7—blood—hypothyroidism	0.00173	0.00672	CbGeAlD
Ziprasidone—Anorexia—Liotrix—hypothyroidism	0.00171	0.00319	CcSEcCtD
Ziprasidone—ADRA2A—heart—hypothyroidism	0.0017	0.0066	CbGeAlD
Ziprasidone—CHRM3—female gonad—hypothyroidism	0.0017	0.00658	CbGeAlD
Ziprasidone—Hypotension—Liotrix—hypothyroidism	0.00168	0.00313	CcSEcCtD
Ziprasidone—ADRA1A—adrenal gland—hypothyroidism	0.00167	0.00648	CbGeAlD
Ziprasidone—ADRA1A—blood—hypothyroidism	0.00167	0.00648	CbGeAlD
Ziprasidone—Diarrhoea—Levothyroxine—hypothyroidism	0.00167	0.00311	CcSEcCtD
Ziprasidone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00167	0.00311	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00164	0.00305	CcSEcCtD
Ziprasidone—Insomnia—Liotrix—hypothyroidism	0.00163	0.00303	CcSEcCtD
Ziprasidone—KCNH2—adrenal gland—hypothyroidism	0.00161	0.00626	CbGeAlD
Ziprasidone—KCNH2—blood—hypothyroidism	0.00161	0.00626	CbGeAlD
Ziprasidone—Paraesthesia—Liotrix—hypothyroidism	0.00161	0.003	CcSEcCtD
Ziprasidone—Dyspnoea—Liotrix—hypothyroidism	0.0016	0.00298	CcSEcCtD
Ziprasidone—ADRA2C—adrenal gland—hypothyroidism	0.00159	0.00618	CbGeAlD
Ziprasidone—ADRA2C—blood—hypothyroidism	0.00159	0.00617	CbGeAlD
Ziprasidone—Decreased appetite—Liotrix—hypothyroidism	0.00156	0.00291	CcSEcCtD
Ziprasidone—Vomiting—Levothyroxine—hypothyroidism	0.00155	0.00289	CcSEcCtD
Ziprasidone—Vomiting—Dextrothyroxine—hypothyroidism	0.00155	0.00289	CcSEcCtD
Ziprasidone—Fatigue—Liotrix—hypothyroidism	0.00155	0.00288	CcSEcCtD
Ziprasidone—Rash—Levothyroxine—hypothyroidism	0.00154	0.00287	CcSEcCtD
Ziprasidone—Rash—Dextrothyroxine—hypothyroidism	0.00154	0.00287	CcSEcCtD
Ziprasidone—Dermatitis—Levothyroxine—hypothyroidism	0.00154	0.00287	CcSEcCtD
Ziprasidone—Dermatitis—Dextrothyroxine—hypothyroidism	0.00154	0.00287	CcSEcCtD
Ziprasidone—Constipation—Liotrix—hypothyroidism	0.00154	0.00286	CcSEcCtD
Ziprasidone—Headache—Dextrothyroxine—hypothyroidism	0.00153	0.00285	CcSEcCtD
Ziprasidone—Headache—Levothyroxine—hypothyroidism	0.00153	0.00285	CcSEcCtD
Ziprasidone—CHRM3—testis—hypothyroidism	0.00151	0.00584	CbGeAlD
Ziprasidone—KCNH2—female gonad—hypothyroidism	0.00151	0.00584	CbGeAlD
Ziprasidone—ADRA2C—female gonad—hypothyroidism	0.00149	0.00576	CbGeAlD
Ziprasidone—Feeling abnormal—Liotrix—hypothyroidism	0.00148	0.00276	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Liotrix—hypothyroidism	0.00147	0.00274	CcSEcCtD
Ziprasidone—ADRA2A—gonad—hypothyroidism	0.00146	0.00565	CbGeAlD
Ziprasidone—Nausea—Dextrothyroxine—hypothyroidism	0.00145	0.0027	CcSEcCtD
Ziprasidone—Nausea—Levothyroxine—hypothyroidism	0.00145	0.0027	CcSEcCtD
Ziprasidone—HTR2A—heart—hypothyroidism	0.00145	0.00561	CbGeAlD
Ziprasidone—HTR7—testis—hypothyroidism	0.00143	0.00556	CbGeAlD
Ziprasidone—Urticaria—Liotrix—hypothyroidism	0.00143	0.00266	CcSEcCtD
Ziprasidone—ADRA2A—pituitary gland—hypothyroidism	0.00142	0.00552	CbGeAlD
Ziprasidone—Body temperature increased—Liotrix—hypothyroidism	0.00142	0.00265	CcSEcCtD
Ziprasidone—Abdominal pain—Liotrix—hypothyroidism	0.00142	0.00265	CcSEcCtD
Ziprasidone—HTR1A—cerebellum—hypothyroidism	0.00139	0.00537	CbGeAlD
Ziprasidone—CYP1A2—blood—hypothyroidism	0.00138	0.00536	CbGeAlD
Ziprasidone—HTR2A—cardiovascular system—hypothyroidism	0.00137	0.0053	CbGeAlD
Ziprasidone—DRD2—testis—hypothyroidism	0.00136	0.00525	CbGeAlD
Ziprasidone—HTR7—liver—hypothyroidism	0.00136	0.00525	CbGeAlD
Ziprasidone—KCNH2—testis—hypothyroidism	0.00134	0.00518	CbGeAlD
Ziprasidone—CYP1A2—thyroid gland—hypothyroidism	0.00133	0.00517	CbGeAlD
Ziprasidone—CYP3A5—blood—hypothyroidism	0.00133	0.00517	CbGeAlD
Ziprasidone—HTR7—cerebellum—hypothyroidism	0.00132	0.00513	CbGeAlD
Ziprasidone—Hypersensitivity—Liotrix—hypothyroidism	0.00132	0.00247	CcSEcCtD
Ziprasidone—ADRA2C—testis—hypothyroidism	0.00132	0.00511	CbGeAlD
Ziprasidone—ADRA1A—liver—hypothyroidism	0.00131	0.00507	CbGeAlD
Ziprasidone—HRH1—adrenal gland—hypothyroidism	0.00129	0.00502	CbGeAlD
Ziprasidone—Asthenia—Liotrix—hypothyroidism	0.00129	0.0024	CcSEcCtD
Ziprasidone—ADRA1A—cerebellum—hypothyroidism	0.00128	0.00495	CbGeAlD
Ziprasidone—ADRA2A—adrenal gland—hypothyroidism	0.00127	0.00493	CbGeAlD
Ziprasidone—ADRA2A—blood—hypothyroidism	0.00127	0.00493	CbGeAlD
Ziprasidone—DRD2—cerebellum—hypothyroidism	0.00125	0.00485	CbGeAlD
Ziprasidone—ADRA2C—liver—hypothyroidism	0.00125	0.00483	CbGeAlD
Ziprasidone—CYP3A5—female gonad—hypothyroidism	0.00124	0.00482	CbGeAlD
Ziprasidone—HTR2A—gonad—hypothyroidism	0.00124	0.00481	CbGeAlD
Ziprasidone—KCNH2—cerebellum—hypothyroidism	0.00123	0.00478	CbGeAlD
Ziprasidone—Diarrhoea—Liotrix—hypothyroidism	0.00123	0.00229	CcSEcCtD
Ziprasidone—ADRA2A—thyroid gland—hypothyroidism	0.00123	0.00476	CbGeAlD
Ziprasidone—ADRA2C—cerebellum—hypothyroidism	0.00122	0.00472	CbGeAlD
Ziprasidone—HTR2A—pituitary gland—hypothyroidism	0.00121	0.00469	CbGeAlD
Ziprasidone—HRH1—female gonad—hypothyroidism	0.00121	0.00468	CbGeAlD
Ziprasidone—Dizziness—Liotrix—hypothyroidism	0.00119	0.00221	CcSEcCtD
Ziprasidone—ADRA2A—female gonad—hypothyroidism	0.00119	0.0046	CbGeAlD
Ziprasidone—Vomiting—Liotrix—hypothyroidism	0.00114	0.00213	CcSEcCtD
Ziprasidone—Rash—Liotrix—hypothyroidism	0.00113	0.00211	CcSEcCtD
Ziprasidone—Dermatitis—Liotrix—hypothyroidism	0.00113	0.00211	CcSEcCtD
Ziprasidone—Headache—Liotrix—hypothyroidism	0.00113	0.0021	CcSEcCtD
Ziprasidone—HTR2A—adrenal gland—hypothyroidism	0.00108	0.00419	CbGeAlD
Ziprasidone—CYP1A2—liver—hypothyroidism	0.00108	0.00419	CbGeAlD
Ziprasidone—HTR2A—blood—hypothyroidism	0.00108	0.00419	CbGeAlD
Ziprasidone—HRH1—testis—hypothyroidism	0.00107	0.00415	CbGeAlD
Ziprasidone—Nausea—Liotrix—hypothyroidism	0.00107	0.00199	CcSEcCtD
Ziprasidone—ADRA2A—testis—hypothyroidism	0.00105	0.00408	CbGeAlD
Ziprasidone—CYP3A5—liver—hypothyroidism	0.00104	0.00404	CbGeAlD
Ziprasidone—CYP3A4—blood—hypothyroidism	0.001	0.00388	CbGeAlD
Ziprasidone—CYP2D6—blood—hypothyroidism	0.000985	0.00382	CbGeAlD
Ziprasidone—ADRA2A—cerebellum—hypothyroidism	0.000971	0.00376	CbGeAlD
Ziprasidone—CYP2D6—female gonad—hypothyroidism	0.000918	0.00356	CbGeAlD
Ziprasidone—HTR2A—testis—hypothyroidism	0.000894	0.00347	CbGeAlD
Ziprasidone—HTR2A—liver—hypothyroidism	0.000845	0.00328	CbGeAlD
Ziprasidone—HTR2A—cerebellum—hypothyroidism	0.000826	0.0032	CbGeAlD
Ziprasidone—CYP2D6—testis—hypothyroidism	0.000814	0.00316	CbGeAlD
Ziprasidone—CYP3A4—liver—hypothyroidism	0.000782	0.00303	CbGeAlD
Ziprasidone—CYP2D6—liver—hypothyroidism	0.00077	0.00298	CbGeAlD
Ziprasidone—CYP2D6—cerebellum—hypothyroidism	0.000752	0.00292	CbGeAlD
Ziprasidone—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	7.38e-05	0.00036	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—AVP—hypothyroidism	7.38e-05	0.00036	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TRH—hypothyroidism	7.37e-05	0.00036	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TRH—hypothyroidism	7.35e-05	0.000358	CbGpPWpGaD
Ziprasidone—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	7.33e-05	0.000358	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	7.28e-05	0.000355	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	7.28e-05	0.000355	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TRH—hypothyroidism	7.28e-05	0.000355	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	7.27e-05	0.000354	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	7.26e-05	0.000354	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TRH—hypothyroidism	7.26e-05	0.000354	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—AVP—hypothyroidism	7.24e-05	0.000353	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	7.22e-05	0.000352	CbGpPWpGaD
Ziprasidone—DRD4—GPCR downstream signaling—POMC—hypothyroidism	7.21e-05	0.000352	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—AVP—hypothyroidism	7.2e-05	0.000351	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—TSHB—hypothyroidism	7.19e-05	0.000351	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	7.13e-05	0.000348	CbGpPWpGaD
Ziprasidone—CHRM4—GPCR downstream signaling—POMC—hypothyroidism	7.11e-05	0.000347	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	7.11e-05	0.000347	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	7.06e-05	0.000344	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.03e-05	0.000343	CbGpPWpGaD
Ziprasidone—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.01e-05	0.000342	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PIK3C2A—hypothyroidism	6.98e-05	0.000341	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—VAV3—hypothyroidism	6.95e-05	0.000339	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	6.85e-05	0.000334	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—POMC—hypothyroidism	6.85e-05	0.000334	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—POMC—hypothyroidism	6.84e-05	0.000334	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	6.84e-05	0.000334	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—PRL—hypothyroidism	6.83e-05	0.000333	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—VAV3—hypothyroidism	6.83e-05	0.000333	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—PRL—hypothyroidism	6.82e-05	0.000333	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—SLC5A5—hypothyroidism	6.82e-05	0.000333	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	6.82e-05	0.000332	CbGpPWpGaD
Ziprasidone—CHRM5—GPCR downstream signaling—POMC—hypothyroidism	6.81e-05	0.000332	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	6.8e-05	0.000332	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—POMC—hypothyroidism	6.8e-05	0.000332	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—VAV3—hypothyroidism	6.78e-05	0.000331	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	6.78e-05	0.000331	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—PRL—hypothyroidism	6.78e-05	0.000331	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TRH—hypothyroidism	6.74e-05	0.000329	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	6.72e-05	0.000328	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TSHB—hypothyroidism	6.71e-05	0.000328	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TSHR—hypothyroidism	6.71e-05	0.000328	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	6.7e-05	0.000327	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AVP—hypothyroidism	6.7e-05	0.000327	CbGpPWpGaD
Ziprasidone—ADRA2A—Hemostasis—IGF1—hypothyroidism	6.68e-05	0.000326	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—POMC—hypothyroidism	6.65e-05	0.000325	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—PRL—hypothyroidism	6.64e-05	0.000324	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—SLC5A5—hypothyroidism	6.62e-05	0.000323	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—TPO—hypothyroidism	6.61e-05	0.000323	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TSHB—hypothyroidism	6.61e-05	0.000322	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TSHR—hypothyroidism	6.61e-05	0.000322	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	6.6e-05	0.000322	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	6.59e-05	0.000322	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TSHR—hypothyroidism	6.59e-05	0.000322	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TSHB—hypothyroidism	6.59e-05	0.000322	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AVP—hypothyroidism	6.59e-05	0.000322	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—TSHB—hypothyroidism	6.59e-05	0.000321	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AVP—hypothyroidism	6.58e-05	0.000321	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TSHB—hypothyroidism	6.57e-05	0.000321	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TSHR—hypothyroidism	6.57e-05	0.000321	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AVP—hypothyroidism	6.56e-05	0.00032	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TSHR—hypothyroidism	6.55e-05	0.00032	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TSHB—hypothyroidism	6.55e-05	0.00032	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—POMC—hypothyroidism	6.55e-05	0.000319	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AVP—hypothyroidism	6.53e-05	0.000319	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—PRL—hypothyroidism	6.53e-05	0.000319	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—POMC—hypothyroidism	6.49e-05	0.000317	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	6.49e-05	0.000317	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TSHB—hypothyroidism	6.49e-05	0.000316	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TSHR—hypothyroidism	6.49e-05	0.000316	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AVP—hypothyroidism	6.47e-05	0.000316	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	6.47e-05	0.000316	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	6.47e-05	0.000316	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—POMC—hypothyroidism	6.46e-05	0.000315	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	6.45e-05	0.000315	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—PRL—hypothyroidism	6.44e-05	0.000314	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	6.41e-05	0.000313	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—POMC—hypothyroidism	6.41e-05	0.000312	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—VAV3—hypothyroidism	6.32e-05	0.000308	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—VAV3—hypothyroidism	6.31e-05	0.000308	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—VAV3—hypothyroidism	6.27e-05	0.000306	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	6.22e-05	0.000304	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—POMC—hypothyroidism	6.19e-05	0.000302	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—PRL—hypothyroidism	6.17e-05	0.000301	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—VAV3—hypothyroidism	6.14e-05	0.0003	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AVP—hypothyroidism	6.09e-05	0.000297	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AVP—hypothyroidism	6.08e-05	0.000297	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—VAV3—hypothyroidism	6.04e-05	0.000295	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AVP—hypothyroidism	6.04e-05	0.000295	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	6.01e-05	0.000293	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	6.01e-05	0.000293	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	6e-05	0.000293	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SH2B3—hypothyroidism	5.98e-05	0.000292	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—VAV3—hypothyroidism	5.96e-05	0.000291	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—POMC—hypothyroidism	5.92e-05	0.000289	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AVP—hypothyroidism	5.92e-05	0.000289	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—POMC—hypothyroidism	5.9e-05	0.000288	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	5.89e-05	0.000287	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—PRL—hypothyroidism	5.88e-05	0.000287	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SH2B3—hypothyroidism	5.88e-05	0.000287	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	5.87e-05	0.000286	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—SLC5A5—hypothyroidism	5.86e-05	0.000286	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	5.86e-05	0.000286	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SH2B3—hypothyroidism	5.84e-05	0.000285	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AVP—hypothyroidism	5.82e-05	0.000284	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—POMC—hypothyroidism	5.82e-05	0.000284	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—PRL—hypothyroidism	5.8e-05	0.000283	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	5.78e-05	0.000282	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	5.78e-05	0.000282	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	5.77e-05	0.000281	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AVP—hypothyroidism	5.74e-05	0.00028	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—VAV3—hypothyroidism	5.71e-05	0.000278	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IGF1—hypothyroidism	5.7e-05	0.000278	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	5.58e-05	0.000272	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	5.55e-05	0.000271	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AVP—hypothyroidism	5.5e-05	0.000268	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—VAV3—hypothyroidism	5.44e-05	0.000265	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	5.4e-05	0.000264	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—SLC5A5—hypothyroidism	5.38e-05	0.000262	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—VAV3—hypothyroidism	5.37e-05	0.000262	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	5.36e-05	0.000261	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	5.32e-05	0.000259	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	5.25e-05	0.000256	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—POMC—hypothyroidism	5.24e-05	0.000256	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AVP—hypothyroidism	5.24e-05	0.000256	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—PRL—hypothyroidism	5.24e-05	0.000256	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AVP—hypothyroidism	5.17e-05	0.000252	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—POMC—hypothyroidism	5.07e-05	0.000247	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—PRL—hypothyroidism	5.06e-05	0.000247	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—POMC—hypothyroidism	5.04e-05	0.000246	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IGF1—hypothyroidism	5.04e-05	0.000246	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—PRL—hypothyroidism	5.03e-05	0.000245	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—SLC5A5—hypothyroidism	4.93e-05	0.000241	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	4.91e-05	0.000239	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—POMC—hypothyroidism	4.9e-05	0.000239	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—PRL—hypothyroidism	4.89e-05	0.000239	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	4.85e-05	0.000236	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	4.83e-05	0.000236	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	4.82e-05	0.000235	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—PRL—hypothyroidism	4.82e-05	0.000235	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—POMC—hypothyroidism	4.81e-05	0.000235	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	4.8e-05	0.000234	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—POMC—hypothyroidism	4.78e-05	0.000233	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	4.74e-05	0.000231	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	4.72e-05	0.00023	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—TSHB—hypothyroidism	4.68e-05	0.000228	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VAV3—hypothyroidism	4.68e-05	0.000228	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AVP—hypothyroidism	4.67e-05	0.000228	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VAV3—hypothyroidism	4.65e-05	0.000227	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	4.53e-05	0.000221	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AVP—hypothyroidism	4.51e-05	0.00022	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AVP—hypothyroidism	4.48e-05	0.000219	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	4.45e-05	0.000217	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—POMC—hypothyroidism	4.45e-05	0.000217	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—PRL—hypothyroidism	4.44e-05	0.000217	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	4.39e-05	0.000214	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—POMC—hypothyroidism	4.38e-05	0.000214	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—POMC—hypothyroidism	4.37e-05	0.000213	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—PRL—hypothyroidism	4.37e-05	0.000213	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AVP—hypothyroidism	4.36e-05	0.000213	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—PRL—hypothyroidism	4.36e-05	0.000213	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—POMC—hypothyroidism	4.36e-05	0.000213	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PRL—hypothyroidism	4.34e-05	0.000212	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—POMC—hypothyroidism	4.34e-05	0.000212	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PRL—hypothyroidism	4.33e-05	0.000211	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—POMC—hypothyroidism	4.3e-05	0.00021	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AVP—hypothyroidism	4.29e-05	0.000209	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PRL—hypothyroidism	4.29e-05	0.000209	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	4.29e-05	0.000209	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PRL—hypothyroidism	4.28e-05	0.000209	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.17e-05	0.000204	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VAV3—hypothyroidism	4.11e-05	0.0002	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—POMC—hypothyroidism	4.05e-05	0.000197	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—POMC—hypothyroidism	4.04e-05	0.000197	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VAV3—hypothyroidism	4.04e-05	0.000197	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VAV3—hypothyroidism	4.03e-05	0.000197	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VAV3—hypothyroidism	4.02e-05	0.000196	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—POMC—hypothyroidism	4.01e-05	0.000196	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VAV3—hypothyroidism	4.01e-05	0.000195	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	3.98e-05	0.000194	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PRL—hypothyroidism	3.97e-05	0.000194	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VAV3—hypothyroidism	3.97e-05	0.000194	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—TSHB—hypothyroidism	3.97e-05	0.000194	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	3.96e-05	0.000193	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AVP—hypothyroidism	3.96e-05	0.000193	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—POMC—hypothyroidism	3.93e-05	0.000192	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AVP—hypothyroidism	3.89e-05	0.00019	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IGF1—hypothyroidism	3.89e-05	0.00019	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IGF1—hypothyroidism	3.89e-05	0.00019	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AVP—hypothyroidism	3.88e-05	0.00019	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AVP—hypothyroidism	3.87e-05	0.000189	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—POMC—hypothyroidism	3.87e-05	0.000189	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IGF1—hypothyroidism	3.86e-05	0.000188	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AVP—hypothyroidism	3.86e-05	0.000188	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AVP—hypothyroidism	3.82e-05	0.000186	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—POMC—hypothyroidism	3.82e-05	0.000186	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AVP—hypothyroidism	3.81e-05	0.000186	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IGF1—hypothyroidism	3.78e-05	0.000184	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IGF1—hypothyroidism	3.72e-05	0.000182	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	3.68e-05	0.000179	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IGF1—hypothyroidism	3.67e-05	0.000179	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—POMC—hypothyroidism	3.65e-05	0.000178	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—POMC—hypothyroidism	3.57e-05	0.000174	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AVP—hypothyroidism	3.54e-05	0.000173	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	3.54e-05	0.000173	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IGF1—hypothyroidism	3.52e-05	0.000172	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.51e-05	0.000171	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.49e-05	0.00017	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—POMC—hypothyroidism	3.48e-05	0.00017	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—POMC—hypothyroidism	3.47e-05	0.000169	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—POMC—hypothyroidism	3.44e-05	0.000168	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IGF1—hypothyroidism	3.35e-05	0.000163	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IGF1—hypothyroidism	3.31e-05	0.000161	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—POMC—hypothyroidism	3.1e-05	0.000151	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—POMC—hypothyroidism	3.07e-05	0.00015	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—TSHB—hypothyroidism	3.06e-05	0.000149	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—POMC—hypothyroidism	2.99e-05	0.000146	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	2.98e-05	0.000146	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—POMC—hypothyroidism	2.98e-05	0.000145	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.97e-05	0.000145	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—POMC—hypothyroidism	2.9e-05	0.000141	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IGF1—hypothyroidism	2.88e-05	0.000141	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IGF1—hypothyroidism	2.87e-05	0.00014	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—POMC—hypothyroidism	2.85e-05	0.000139	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—POMC—hypothyroidism	2.81e-05	0.000137	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	2.79e-05	0.000136	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	2.74e-05	0.000134	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.73e-05	0.000133	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—POMC—hypothyroidism	2.63e-05	0.000128	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—POMC—hypothyroidism	2.59e-05	0.000126	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—POMC—hypothyroidism	2.58e-05	0.000126	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—POMC—hypothyroidism	2.58e-05	0.000126	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—POMC—hypothyroidism	2.57e-05	0.000126	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—POMC—hypothyroidism	2.57e-05	0.000125	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—POMC—hypothyroidism	2.54e-05	0.000124	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—POMC—hypothyroidism	2.53e-05	0.000124	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IGF1—hypothyroidism	2.53e-05	0.000123	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IGF1—hypothyroidism	2.49e-05	0.000121	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF1—hypothyroidism	2.48e-05	0.000121	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF1—hypothyroidism	2.48e-05	0.000121	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF1—hypothyroidism	2.47e-05	0.00012	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF1—hypothyroidism	2.44e-05	0.000119	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	2.44e-05	0.000119	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—POMC—hypothyroidism	2.35e-05	0.000115	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.29e-05	0.000112	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	2.26e-05	0.00011	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—POMC—hypothyroidism	1.83e-05	8.95e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—POMC—hypothyroidism	1.55e-05	7.58e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—POMC—hypothyroidism	1.2e-05	5.85e-05	CbGpPWpGaD
